` TECH (Bio-Techne Corp) vs S&P 500 Comparison - Alpha Spread

TECH
vs
S&P 500

Over the past 12 months, TECH has outperformed S&P 500, delivering a return of +24% compared to S&P 500's +13% growth.

Stocks Performance
TECH vs S&P 500

Loading...
TECH
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
TECH vs S&P 500

Performance Gap Between TECH and GSPC

Create a free account · No card needed

Performance By Year
TECH vs S&P 500

Loading...
TECH
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Bio-Techne Corp vs Peers

S&P 500
TECH
TMO
DHR
603259
LONN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Bio-Techne Corp
Glance View

Bio-Techne makes the tools scientists use to study cells and disease. Its products include antibodies, proteins, assays, cell and gene therapy reagents, and instruments used in life-science research and clinical testing. The company also sells diagnostic products that help labs detect and monitor certain medical conditions. Its main customers are drug developers, academic and government research labs, biotech companies, and clinical laboratories. Bio-Techne makes money by selling these consumable products, along with instruments and related services, through direct sales and distributors. Because many of its products are used repeatedly in research and testing workflows, it plays a steady supplier role in the life-science supply chain. What makes Bio-Techne different is that it sits close to the basic science stage of medicine. Instead of making finished drugs, it sells the specialized materials and testing tools that other companies and labs need to discover, develop, and validate those drugs and diagnostics. That gives it exposure to a wide range of research and healthcare end markets.

TECH Intrinsic Value

Create a free account · No card needed

Back to Top